Clinical trial
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
NCT04378153 is registered in ClinicalTrials.gov with Nicole Hamblett as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
- Lead sponsor
- Nicole Hamblett
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 25, 2020
- Completion date
- July 11, 2022
- Enrollment
- 987 (actual)
- Sites
- 80
Conditions
As the registry lists them; a condition with its own page is linked.